Insulin Resistance: The Blood Test Your Annual Physical Skips
Metabolic Health
Insulin resistance: the blood test your annual physical skips.
Your glucose was normal. Your A1c was fine. Your body may still be working twice as hard to keep it that way.
The lab sheet says normal across the board. She is 41, eating better than she ever has, walking every day, and her waist keeps growing. Her energy crashes after lunch. She has new skin tags on her neck. She was told she is fine.
Nobody was wrong about the numbers on the page. The one that mattered was never ordered.
Then we run a fasting insulin test, and it is high. That is insulin resistance. And it was there the whole time.
What insulin resistance actually is
Insulin moves sugar out of your blood and into your cells. When the cells stop responding well, the pancreas answers by making more. Think of a voice getting louder because the room stopped listening. For years, sometimes a decade, that extra insulin keeps blood sugar inside the normal range.
So your glucose looks fine. Your A1c looks fine. Underneath, insulin is running high to hold the line, and high insulin itself pushes fat storage, raises triglycerides, and nudges blood pressure up.
None of this is new. Gerald Reaven laid out the link between insulin resistance, high blood pressure, abnormal lipids, and heart disease in his 1988 Banting lecture. The research since has filled in the details. Routine screening never caught up.
Why insulin resistance gets missed on a routine physical
A routine physical usually checks fasting glucose, and sometimes A1c. Both measure sugar. Neither measures how hard your body is working to control it. The USPSTF recommends screening adults 35 to 70 who have overweight or obesity with glucose or A1c, and those tests do catch prediabetes and diabetes. They were never built to catch the stage before.
The Whitehall II study followed more than 6,500 adults for about a decade. In the people who went on to develop type 2 diabetes, insulin sensitivity fell steeply over the five years before diagnosis, while fasting glucose crept up slowly and then jumped in the final three.
Fasting glucose is a late marker. By the time it climbs out of range, the pancreas has often been overworking for years. But a normal glucose is not the same as a healthy metabolism.
The fasting insulin test, and what it adds
A fasting insulin test is a simple blood draw done alongside your glucose. Together they produce a calculation called HOMA-IR, first described in 1985, which correlated closely with the clamp studies researchers use to measure insulin resistance directly.
Timing matters. Draw it truly fasting, first thing in the morning, with nothing but water. A late snack or a sweetened coffee on the way to the lab pushes insulin up and makes the result useless.
Labs do not agree on a single cutoff for fasting insulin, and assays differ. So I read it in context, next to these:
Fasting insulin with glucose
The core pair, and the basis for HOMA-IR.
A1c
Your three-month sugar average. Useful, but slow to change.
Triglycerides and HDL
High triglycerides with low HDL is a classic insulin resistance pattern, and it shows up on a standard lipid panel.
Liver enzymes
Fat in the liver travels with insulin resistance and often shows up first as a mild rise in ALT.
I also look at blood pressure and waist size at the same visit. A waist that has grown while weight held steady points straight at visceral fat, and visceral fat travels with insulin resistance.
Signs worth paying attention to
- Weight gain that settles around the waist
- Energy crashes or shakiness a couple of hours after meals
- Skin tags or dark, velvety skin at the neck or underarms
- Irregular cycles or PCOS
- Rising blood pressure or triglycerides
- A parent or sibling with type 2 diabetes
No single sign proves insulin resistance. Two or three together are a strong reason to test, especially if your glucose has read normal for years while everything else drifted.
Women with PCOS deserve this test early, because insulin resistance drives much of what that condition does. Men are not exempt either. A growing belly, low energy, and a low testosterone result often sit on top of the same metabolic problem.
Caught here, it responds well to protein, strength training, better sleep, and fewer liquid sugars. Caught at diabetes, the work is harder and the options narrow.
And the plan is rarely dramatic. More protein at breakfast. Two or three strength sessions a week. A walk after dinner. An earlier bedtime. Small changes done consistently move fasting insulin, and a recheck in a few months shows whether the plan is working instead of waiting years for A1c to finally move.
How we check it at Navara
Our Weight Loss and Metabolic Evaluation is $189 and includes your consultation, testing at any Quest location, and a results review where we go through every number with you. Consults are virtual, so patients in Dallas and beyond can draw at a Quest near home or work.
If fasting insulin is high, we build the plan around protein, muscle, sleep, and medical treatment when it is appropriate. Then we recheck. The number should move, and you should feel it before you see it. Steadier energy after lunch is often the first sign, and a looser waistband usually follows.
Fasting insulin, the full metabolic picture, and a real review of what it means for you.
See Lab PanelsThis article is general education, not medical advice for any individual. Talk with your own clinician about what fits your history.
Written and clinically reviewed by Jessica Boggs, MSN, APRN, FNP-C, ENP-C, founder of Navara Health. Medical oversight by Simal Patel, MD.
Last reviewed November 16, 2026. This page is general information, not medical advice, and does not create a provider relationship.
Sources
- Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221.
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
- US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743.
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
